Clinical trial
Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin
NCT00461916 · Tehran University of Medical Sciences, Other · Completed
Key facts
| NCT number | NCT00461916 |
|---|---|
| Title | Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin |
| Official title | Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin in a Long Protocol of Controlled Ovarian Stimulation for ICSI/ET |
| Lead sponsor | Tehran University of Medical Sciences, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Infertility |
| Intervention type | Drug |
| Interventions | Half-Dose Depot Triptorelin, Reduced-Dose Daily Buserelin |
| Enrollment | 182 |
| Start date | May 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Apr 18, 2007 |
| Last update posted | Apr 18, 2007 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: